Premium
Tacrolimus suppresses IL‐12/IL23 p40 in Crohn’s disease and heals fistulae refractory to anti‐TNF‐α therapy: authors’ reply
Author(s) -
Tozer P. J.,
Burling D.,
Gupta A.,
Phillips R. K. S.,
Hart A. L.
Publication year - 2011
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2011.04597.x
Subject(s) - medicine , tacrolimus , refractory (planetary science) , crohn's disease , regimen , adalimumab , sepsis , placebo , surgery , infliximab , gastroenterology , disease , transplantation , pathology , physics , alternative medicine , astrobiology